# Glucocorticoids and Skin Healing in Diabetes (GC-SHealD)

> **NCT03313297** · PHASE2 · COMPLETED · sponsor: **University of Leeds** · enrollment: 28 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** AZD4017
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03313297
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-10
- **Primary completion:** 2019-02-27
- **Final completion:** 2019-03-13
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03313297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03313297, "Glucocorticoids and Skin Healing in Diabetes (GC-SHealD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03313297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*